5-fluorouracil • Bavencio (avelumab) • albumin-bound paclitaxel • cyclophosphamide • leucovorin calcium • Anktiva (nogapendekin alfa inbakicept-pmln) • ETBX-011 • ETBX-051 • ETBX-061 • GI-4000 • GI-6207 • GI-6301 • NK92-CD16-158V • aldoxorubicin (INNO-206)

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. (NCT03387085)

Phase 1/2

ImmunityBio, Inc.

Active, not recruiting

Phase 1/2

ImmunityBio, Inc.

Active, not recruiting

Last update posted :

09/27/2023

Initiation :

03/16/2018

Primary completion :

09/01/2023

Completion :

10/01/2023

HER-2 • ER • PGR

HER-2 overexpression • HER-2 amplification • PGR expression

Avastin (bevacizumab) • cisplatin • 5-fluorouracil • Bavencio (avelumab) • capecitabine • albumin-bound paclitaxel • cyclophosphamide • leucovorin calcium • Anktiva (nogapendekin alfa inbakicept-pmln) • ETBX-011 • ETBX-051 • ETBX-061 • GI-4000 • GI-6207 • GI-6301 • NK92-CD16-158V • aldoxorubicin (INNO-206)

GI-4000 With Adoptive Transfer in Pancreatic Cancer (NCT00837135)

Phase 1

University of Pennsylvania

Withdrawn

Phase 1

University of Pennsylvania

Withdrawn

Last update posted :

08/17/2016

Initiation :

01/01/2008

Primary completion :

10/01/2009

Completion :

10/01/2009

KRAS

KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12 • KRAS Q61L • KRAS expression

GI-4000

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer (NCT00300950)

Phase 2

GlobeImmune

Completed

Phase 2

GlobeImmune

Completed

Last update posted :

04/06/2015

Initiation :

01/01/2006

Primary completion :

02/01/2015

Completion :

02/01/2015

RAS

RAS mutation

gemcitabine • GI-4000

GI-4000

Trials

Trials